Pediatric Renal FailureIPPNCT07339709
Intraperitoneal Pressure Measurements Survey in Pediatric Centers
An observational study of Pediatric Renal Failure, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Intraperitoneal pressure (IPP) is an objective measurement used to assess tolerance to fluid volume. IPP has been shown to be strongly correlated with intraperitoneal dialysate volume as well as anthropometric parameters. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pediatric Renal Failure
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 16 Jul 2025to 16 Jul 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Healthcare professional working in a European dialysis center
Who may be able to join
- Healthcare professional working in a European dialysis center
Who cannot join
- Refusal to participate in the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, 67091
Ariane ZALOSZYC, MD, PhD, 33 3 88 12 77 42, ariane.zaloszyc@chru-strasbourg.fr
Ariane ZALOSZYC, MD, PhD
About this study
Intraperitoneal pressure (IPP) is an objective measurement used to assess tolerance to fluid volume. IPP has been shown to be strongly correlated with intraperitoneal dialysate volume as well as anthropometric parameters. In observational studies conducted in adults, an IPP greater than 13-14 cmH2O was associated with an increased risk of peritonitis, initiation of hemodialysis, or death.
Measuring IPP is therefore a tool to optimize dialysis prescriptions. However, this measurement is not well standardized, and there is limited scientific evidence regarding its impact on patient management.
Read more
Measuring IPP is a tool to optimize dialysis prescriptions. However, this measurement is not well standardized, and there is limited scientific evidence regarding its impact on patient management. Some centers do not perform any measurements, others perform them monthly, and some only during peritoneal equilibration tests.
The hypothesis of this research is to highlight current practices and experiences in measuring intraperitoneal pressures in children undergoing peritoneal dialysis in different European dialysis centers, in order to improve practices regarding PIP prescription.
- Conditions
- Pediatric Renal Failure
- Keywords
- Pediatric Renal Failure, Peritoneal dialysis, Intraperitoneal pressure, Intraperitoneal dialysates, End-stage renal disease
- Medical subject headings
- Kidney Failure, Chronic
What is being measured
The primary outcome is the main question the study is designed to answer.
Review of current practices in measuring intraperitoneal pressures in children undergoing peritoneal dialysis
This study aims to provide an overview of current experiences in measuring intraperitoneal pressures in children undergoing peritoneal dialysis in different European dialysis centers.
Measured: Up to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start16 Jul 2025
- Primary completionJul 2026 (estimated)
- Study completion16 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pediatric Renal FailureStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07339709
- Sponsor's protocol ID
- 9764
- Acronym
- IPP
- Status last verified
- Jan 2026
- First submitted
- 5 Jan 2026
- Last updated
- 14 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Intraperitoneal Pressure Measurements Survey in Pediatric Centers
- ClinicalTrials.gov ID
- NCT07339709
- Acronym / sponsor ID
- IPP / 9764
- Conditions
- Pediatric Renal Failure
- Keywords
- Pediatric Renal Failure, Peritoneal dialysis, Intraperitoneal pressure, Intraperitoneal dialysates, End-stage renal disease
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 16 Jul 2025 (actual)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- 16 Jul 2026 (estimated)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Intraperitoneal pressure (IPP) is an objective measurement used to assess tolerance to fluid volume. IPP has been shown to be strongly correlated with intraperitoneal dialysate volume as well as anthropometric parameters. In observational studies conducted in adults, an IPP greater than 13-14 cmH2O was associated with an increased risk of peritonitis, initiation of hemodialysis, or death.
Measuring IPP is therefore a tool to optimize dialysis prescriptions. However, this measurement is not well standardized, and there is limited scientific evidence regarding its impact on patient management.
Measuring IPP is a tool to optimize dialysis prescriptions. However, this measurement is not well standardized, and there is limited scientific evidence regarding its impact on patient management. Some centers do not perform any measurements, others perform them monthly, and some only during peritoneal equilibration tests.
The hypothesis of this research is to highlight current practices and experiences in measuring intraperitoneal pressures in children undergoing peritoneal dialysis in different European dialysis centers, in order to improve practices regarding PIP prescription.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Healthcare professional working in a European dialysis center
Key inclusion criteria (1 listed)
- Healthcare professional working in a European dialysis center
Key exclusion criteria (1 listed)
- Refusal to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Review of current practices in measuring intraperitoneal pressures in children undergoing peritoneal dialysis
Time frame: Up to 12 months
This study aims to provide an overview of current experiences in measuring intraperitoneal pressures in children undergoing peritoneal dialysis in different European dialysis centers.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2026.
Related trials for Pediatric Renal Failure
RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Berger Disease, Bergers Disease
Recruiting
Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study
Pediatric Kidney Disease, Transplant;Failure,Kidney
Not yet recruiting
Comparative Feasibility and Effectiveness of Medically Tailored Meals Approaches for Pediatric End-Stage Kidney Disease
End Stage Kidney Disease (ESKD)
Not yet recruitingPhase 3
A Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism
Not yet recruitingPhase 3
Ramipril vs. Amlodipine in Pediatric Hemodialysis Patients
Endothelial Dysfunction, End-Stage Renal Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pediatric Renal Failure, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ariane ZALOSZYC, MD, PhD (33 3 88 12 77 42, ariane.zaloszyc@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Review of current practices in measuring intraperitoneal pressures in children undergoing peritoneal dialysis (time frame: Up to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.